The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer

Aldehyde dehydrogenase 1 (ALDH1) and CD44 have been established as biomarkers for predicting the survival of many types of cancer patients. This study evaluated the expression and clinical significance of these putative cancer-cell markers in a series of tumor samples from endometrial cancer (EC) pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsin-Hui, Wang, Yu-Chi, Chou, Yu-Ching, Yu, Mu-Hsien, Chao, Tai-Kuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205661/
https://www.ncbi.nlm.nih.gov/pubmed/30372483
http://dx.doi.org/10.1371/journal.pone.0206685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205661/
https://www.ncbi.nlm.nih.gov/pubmed/30372483
http://dx.doi.org/10.1371/journal.pone.0206685

Ejemplares similares